Clinical Trial Update: Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy and safety of YAM80 in amyotrophic lateral sclerosis, sponsored by Yoshino Neurology Clinic; current results and stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• YAM80

Snippet

Sponsor: Yoshino Neurology Clinic | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN